急性髓性白血病的治疗生物标志物:功能和基因组方法
Karanpreet Bhatia1, Vedant Sandhu1, Mei Hsuan Wong1
1Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Frontiers in oncology
|February 27, 2024
概括
在急性髓性白血病 (AML) 中,精准医学使用基因组生物标志物进行向治疗. 功能性方法提供了更广泛的潜力,但需要标准化以实现有效的体外预测和改善患者的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 急性髓性白血病 (AML) 是一种具有多种基因突变的异质癌症.
- 目前在AML中的精准医学依赖于基因组生物标志物用于向治疗,只受益于一小部分患者.
- 可行的目标的局限性需要探索替代方法,以获得更广泛的患者利益.
研究的目的:
- 审查AML治疗的基因组和功能治疗生物标志物.
- 讨论与AML当前精准医学策略相关的挑战.
- 概述未来的方向,以加强在AML中精准医学的实施.
主要方法:
- 已确定的基因组生物标志物 (例如,IDH1/2,FLT3突变) 和它们的向抑制剂的摘要.
- 探索新兴的功能技术,包括定量表型分析和来自患者的化身模型.
- 分析功能精准医学标准化方面的挑战,例如药物度和暴露时间.
主要成果:
- 基因组测序改善了结果,但由于目标流行率低,其适用性有限.
- 功能精密医学方法显示出更广泛应用的希望,但面临标准化障碍.
- 功能参数的标准化对于可靠的体外药物预测至关重要.
结论:
- 基因组和功能生物标志物对于推动AML精密医学的发展至关重要.
- 克服功能性试验中的标准化挑战是释放其全部潜力的关键.
- 未来的战略应侧重于整合和标准化各种方法,以有效地个性化AML治疗.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
88
相关概念视频
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...